240: #JPM23, the future of Alzheimer's, & rising Covid variants
The Readout Loud
00:00
Is Lacanima Going to Be That?
When Addu Home was approved before all the, you know, bad stuff started happening, there was this expectation that this could be like the biggest drug of all time. Is Lacanima going to be that? Or are we just seeing like a slower phase in of new Alzheimer's medicines? I think the latter, I think the Addu Home debacle was in many ways a chastening experience, obviously for Biogen, which changed out its upper management after it happened.
Transcript
Play full episode


